B cells and tertiary lymphoid organs in renal inflammation

Kidney International

Volumn 73, Issue 5, 2008, Pages 533-537

  Segerer, S ^a,c   Schlondorff D ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

B cells; Chemokines; Dendritic cells; Glomerulonephritis; Leukocyte recruitment; Macrophages

Indexed keywords

AUTOANTIGEN; CYTOKINE;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL AGGREGATION; CELL INFILTRATION; CYTOKINE RELEASE; DENDRITIC CELL; GLOMERULOPATHY; HUMAN; IMMUNE RESPONSE; INTERSTITIAL NEPHRITIS; LYMPH VESSEL; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MEMBRANOUS GLOMERULONEPHRITIS; NEPHRITIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 39349086389     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002734     Document Type: Short Survey

References (38)

1. Acosta-Rodriguez EV, Merino MC, Montes CL et al. Cytokines and chemokines shaping the B-cell compartment. Cytokine Growth Factor Rev 2007; 18: 73-83.
2. Vascotto F, Le Roux D, Lankar D et al. Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. Curr Opin Immunol 2007; 19: 93-98.
3. Wong FS, Wen L. B cells in autoimmune diabetes. Rev Diabet Stud 2005; 2: 121-135.
4. Silverman GJ. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms. Arthritis Rheum 2006; 54: 2356-2367.
5. Angeli V, Ginhoux F, Llodra J et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006; 24: 203-215.
6. Martin F, Chan AC. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006; 24: 467-496.
7. Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006; 6: 394-403.
8. Blum KS, Pabst R. Keystones in lymph node development. J Anat 2006; 209: 585-595.
9. Picker LJ. Mechanisms of lymphocyte homing. Curr Opin Immunol 1992; 4: 277-286.
10. Cyster JG, Ngo VN, Ekland EH et al. Chemokines and B-cell homing to follicles [in process citation]. Curr Top Microbiol Immunol 1999; 246: 87-92.
11. Ebisuno Y, Tanaka T, Kanemitsu N et al. Cutting edge: the B cell chemokine CXC chemokine ligand 13/B lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer's patches and affects B cell trafficking across high endothelial venules. J Immunol 2003; 171: 1642-1646.
12. Muller G, Lipp M. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation 2003; 10: 325-334.
13. Ma Q, Jones D, Borghesani PR et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95: 9448-9453.
14. Salama AD, Pusey CD. Drug insight: rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2006; 2: 221-230.
15. Novobrantseva TI, Majeau GR, Amatucci A et al. Attenuated liver fibrosis in the absence of B cells. J Clin Invest 2005; 115: 3072-3082.
16. Chan OT, Hannum LG, Haberman AM et al. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189: 1639-1648.
17. Lehnhardt A, Mengel M, Pape L et al. Nodular B-cell aggregates associated with treatment refractory renal transplant rejection resolved by rituximab. Am J Transplant 2006; 6: 847-851.
18. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006; 6: 205-217.
19. Sarwal M, Chua MS, Kambham N et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125-138.
20. Tsai EW, Rianthavorn P, Gjertson DW et al. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 2006; 82: 1769-1773.
21. Mengel M, Gwinner W, Schwarz A et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7: 356-365.
22. Kayler LK, Lakkis FG, Morgan C et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007; 7: 949-954.
23. Genberg H, Hansson A, Wernerson A et al. Pharmacodynamics of rituximab in kidney allotransplantation. Am J Transplant 2006; 6: 2418-2428.
24. Steinmetz OM, Panzer U, Kneissler U et al. BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005; 67: 1616-1621.
25. Steinmetz OM, Stahl RA, Panzer U. Formation of lymphoid-like tissue in the kidney - is there a role for chemokines? Nephrol Dial Transplant 2007; 22: 350-352.
26. Kerjaschki D, Regele HM, Moosberger I et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol 2004; 15: 603-612.
27. Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987; 31: 964-972.
28. Cohen CD, Calvaresi N, Armelloni S et al. CD20-positive infiltrates in human membranous glomerulonephritis. J Nephrol 2005; 18: 328-333.
29. Heller F, Lindenmeyer MT, Cohen CD et al. The contribution of B cells to renal interstitial inflammation. Am J Pathol 2007; 170: 457-468.
30. Segerer S, Cui Y, Eitner F et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518-531.
31. Segerer S, Regele H, Mack M et al. The duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000; 58: 1546-1556.
32. Girard JP, Baekkevold ES, Yamanaka T et al. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999; 155: 2043-2055.
33. Marinkovic T, Garin A, Yokota Y et al. Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J Clin Invest 2006; 116: 2622-2632.
34. Ishikawa S, Matsushima K. Aberrant B1 cell trafficking in a murine model for lupus. Front Biosci 2007; 12: 1790-1803.
35. Furtado GC, Marinkovic T, Martin AP et al. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc Natl Acad Sci USA 2007; 104: 5026-5031.
36. Corcione A, Casazza S, Ferretti E et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA 2004; 101: 11064-11069.
37. Taylor RP, Lindorfer MA. Drug insight: the mechanism of action of rituximab in autoimmune disease - the immune complex decoy hypothesis. Nat Clin Pract Rheumatol 2007; 3: 86-95.
38. Eisenberg R. Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20). Endocr Metab Immune Disord Drug Targets 2006; 6: 345-350.